Related Experiment Video
Updated: Jun 18, 2026

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
Published on: July 6, 2012
Mannan-Containing Polymers from Hadal Bacterium Psychrobacter pulmonis: Preparation, Structural Analysis,
Mingxing Qi1, Shuqiang Yan1, Yukun Cui2
1College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Abstract:
Microbial exopolysaccharides from extreme environments are increasingly becoming valuable candidates for drug development. In this study, four fractions named XL-1, XMRS-1, XL-1-D, and XMRS-1-D were isolated and purified from the hadal bacterium Psychrobacter pulmonis by column chromatography. The structural features of these fractions were characterized by molecular weight, monosaccharide composition, Fourier transform infrared (FTIR) spectrum, amino acid analysis and NMR. The results showed that XL-1 and XMRS-1 were mainly composed of mannose, glucose, and glucosamine, while XL-1-D and XMRS-1-D were mainly composed of mannose. In vitro bioactivity assays demonstrated that all four fractions significantly enhanced RAW264.7 macrophage proliferation and phagocytosis, stimulated nitric oxide (NO) and reactive oxygen species (ROS) production, and induced the secretion of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and the expression of inducible nitric oxide synthase (iNOS) mRNA. Moreover, plate cloning tests, cell scratch tests, and apoptosis assays, along with RT-qPCR analysis, demonstrated that the four fractions significantly inhibited A549 cells' proliferation. Specifically, XMRS-1 and XMRS-1-D upregulated Bax, Caspase-3, Caspase-8, and Caspase-9, while downregulating Bcl-2, suggesting transcriptional activation of apoptosis-related pathways. These results offered a reference for the further development and utilization of this hadal bacterium in the future.
Insights
Exopolysaccharides from the hadal bacterium Psychrobacter pulmonis enhance immune cell activity and inhibit cancer cell proliferation. These microbial compounds show promise for drug development, particularly for their anti-cancer properties.
Area of Science:
- Microbiology
- Biochemistry
- Immunology
- Pharmacology
Background:
- Microbial exopolysaccharides from extreme environments are valuable for drug discovery.
- Hadal bacteria like Psychrobacter pulmonis are underexplored sources of bioactive compounds.
Purpose of the Study:
- To isolate and characterize exopolysaccharides from Psychrobacter pulmonis.
- To evaluate the immunomodulatory and anti-cancer effects of these exopolysaccharides.
Main Methods:
- Isolation and purification using column chromatography.
- Structural characterization via FTIR, NMR, and monosaccharide analysis.
- In vitro assays for macrophage activity and cancer cell proliferation/apoptosis.
Main Results:
- Four exopolysaccharide fractions (XL-1, XMRS-1, XL-1-D, XMRS-1-D) were purified.
- All fractions enhanced macrophage proliferation, phagocytosis, and cytokine production (IL-6, TNF-α).
- Fractions inhibited A549 lung cancer cell proliferation and induced apoptosis via upregulation of pro-apoptotic genes.
Conclusions:
- Exopolysaccharides from Psychrobacter pulmonis possess significant immunomodulatory and anti-cancer properties.
- These compounds demonstrate potential for therapeutic applications in drug development.
- Further research into hadal bacterium-derived exopolysaccharides is warranted.
Related Concept Videos
Special Staining Techniques
Determinants of Bacterial Pathogenicity and Virulence
Atypical Pneumonia
Pneumonia I: Introduction

